Main Menu
Trials tagged with: "cll210"

CLL210 (OfaDexRev)
A Phase II Trial of Ofatumumab, Dexamethasone and Lenalidomide Followed by Randomisation to Lenalidomide Maintenance Versus No Further Treatment for High-Risk CLL.
A Phase II Trial of Ofatumumab, Dexamethasone and Lenalidomide Followed by Randomisation to Lenalidomide Maintenance Versus No Further Treatment for High-Risk CLL.